This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-30 April 2026
Vienna Congress & Convention CenterVienna, Austria
Book Now
Menu
Book
Key Sessions
Giancarlo Francese, PhD
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
Gates Foundation
Renske Hesselink
AI for Rapid Response: How Digital Technologies can Accelerate Vaccine Development
CEPI
keyboard_arrow_right

Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 1 of 1 Streams
08:30 - 08:55
Registration & Morning Coffee
Showing 1 of 1 Streams
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30KEYNOTE
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
  • Giancarlo Francese, PhD - Senior Program Officer, Gates Foundation
09:30 - 10:00
AI for Rapid Response: How Digital Technologies can Accelerate Vaccine Development
  • Renske Hesselink - Director PDM Innovations, CEPI
Morning Break
Showing 2 of 2 Streams
10:00 - 10:45
Morning Networking Break in the Exhibit Hall
10:00 - 10:45
Innovation Showcase: Poster Viewing

Explore a showcase of scientific excellence. Discover the latest data and technical breakthroughs in our dedicated Poster Hall in the Exhibit Hall. Engage directly with the authors to discuss their findings, methodology, and results during this focused networking break.

Showing 5 of 5 Streams
10:45 - 10:50
Chairperson's Opening Remarks
  • Lekan Daramola - Consultant, LD BioConsulting Limited
10:50 - 11:20
Cracking the Bispecific Code: A Multi-Pronged Approach to Chain Pairing and Expression

  • Maximising correct heterodimer assembly by synergy between viral vector engineering & host cell engineering

  • Implementation of advanced analytical strategies in early screening process

  • Enabling clone selection based on quality attributes, not just titre

  • Increasing final yield of correctly formed bi-specific antibody

11:20 - 11:50
Fast-Tracking Implementation of Engineered CHO Host Cell Lines: Directed Evolution of Bioprocess Platforms
  • Preethi Krishnaraj - Post.Doc, Boehringer Ingelheim
11:50 - 12:20
Scientific Spotlight: Advanced Instruments
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Glycosylation control and reduction of unwanted high-mannose glycans
  • Michael Butler - Principal Investigator, Cell Technology, NIBRT
11:20 - 11:50
Combining data driven and mechanistic models to assist in-silico media optimisation for fed-batch CHO cultures
  • Bhagya Yatipanthalawa - Research Fellow, The University of Melbourne / ARC Digital Bioprocess Development Hub
11:50 - 12:20
Scientific Spotlight: Thermo Fisher Scientific
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Efficient host cell protein clearance: A study of membrane adsorbers and resins in biopharmaceutical processes
  • Ernest Šprager - Expert Science & Technology, DSPD, Novartis Technical Research & Development
11:20 - 11:50
Beyond Protein A: Building a Non-Affinity Purification Toolbox for the Post-mAb Era
  • Johannes Buyel - Head of Department, BOKU, Austria
11:50 - 12:20
Plot your path to higher productivity
  • Mark Schofield - Director, Science, Cytiva
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Reconfiguring Biopharmaceutical Manufacturing: Evaluating the Multi-Modal Paradigm
  • Andrea Johnston - Senior Director, BioPhorum
11:20 - 11:50
Smart bioprocessing by hybrid R&D: enabling scalable CAR-T and stem cell manufacturing
  • Jan Schrooten - CEO, Antleron
11:50 - 12:20
Novel Large-Pore Cellulose Particles for Advanced Therapeutic Modalities: Efficient Viral Vector Purification
  • Chigusa Mori - Research Scientist, JNC Corporation
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Beyond the Black Box: Utilising Physics-Informed AI to Build Trustworthy Digital Twins for Bioprocessing
  • Ignasi Bofarull-Manzano - : Industrial PhD Candidate, Senior CMC Data Scientist and Consultant, RWTH Aachen University
11:20 - 11:50
From In Silico Optimisation to Real-Time Process Control with Hybrid Modelling and PAT Integration
  • Moo Sun Hong - Assistant Professor, Seoul National University
11:50 - 12:20
Scientific Spotlight: In Silico Optimisation & Real-Time Process Control

Have a Solution for This Challenge?

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

Showing 1 of 1 Streams
12:20 - 13:40
Lunch in the Exhibit Hall
Showing 5 of 5 Streams
13:40 - 13:45
Chairperson's Opening Remarks
  • Lekan Daramola - Consultant, LD BioConsulting Limited
13:45 - 14:15
Growing Biologics: Plant-Based Systems as a Scalable, Cost-Effective Alternative

  • Can transient expression in plants provide a method for rapid, scalable production of complex proteins?

  • Overcoming historical challenges associated with plant-based systems:

    • Differences in glycoform patterns

    • Downstream complexities

  • Advantages in scalability, cost, & safety with plant-based systems

14:15 - 14:45
Reimagining Biomanufacturing: Scalable Cell-Free Approaches for Vaccines and Therapeutics
  • Rochelle Aw - Assistant Professor in the School of Life Sciences, University of Nottingham
14:45 - 15:15
Scientific Spotlight: Pathoquest
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
Key Strategies for Raw Material Readiness
  • Melanie Dannemeyer - Associate Director, Biopharma Drug Substance, AstraZeneca
14:15 - 14:45
Scaling Up Intensification: Overcoming Clarification Bottlenecks at the Primary Recovery Stage
  • Patrick Harnedy - Senior Principal Engineer, Eli Lilly
14:45 - 15:15
Scientific Spotlight: Asahi Kasei
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
Magnetic Beads for Cell Separation and Purification: A Scalable, Column-Free Approach
  • Sebastian Schwaminger - Associate Professor, Medical University of Graz
14:15 - 14:45
Achieve Manufacturing Efficiencies Without Compromise

CDMOs and pharmaceutical companies face ongoing challenges of maximizing downstream processing efficiency, reducing operational costs, and expanding global operations without sacrificing product quality. Achieving these goals demands the careful selection of purification technologies that can withstand higher concentrations of caustic cleaning-in-place (CIP) solution, minimize ligand leakage, and optimize processes to prevent aggregation . These solutions must also offer extended life cycles, ensuring continued performance and productivity.

14:45 - 15:15
Reduce bottlenecks and gain efficiency through innovation in buffer preparation and management
  • Shannon J. Ryan, Ph.D - Senior Director, Application Services, Avantor
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
From Open Bench to Closed System: Cell Therapy Manufacturing
  • Subash Ramamoorthy - Principal Automation & Robotics, Bayer AG
14:15 - 14:45
Industrializing 'Off-the-Shelf' Therapies: Scaling Stem Cell-Derived Cell Therapy Manufacturing
  • Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:45 - 15:15
Scientific Spotlight: Merck
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
A First-Principles based Framework for Risk Reduction in scale-up and transfer of Bioprocesses
  • Christian Witz - CEO, SimVantage GmbH
14:15 - 14:45
CASE STUDY: Implementing In-Line PAT for Real-Time Process Control
  • A Representative from Johnson & Johnson Innovative Medicine - (Pending Final Confirmation), Johnson & Johnson Innovative Medicine
14:45 - 15:15
Scientific Spotlight: ArgusEye AB
Showing 1 of 1 Streams
15:15 - 16:00
Afternoon Break in the Exhibit Hall
Showing 5 of 5 Streams
16:00 - 16:30
The AAV Holy Grail: Building a Stable, Scalable Producer Cell Line

  • Overcoming the limitations of industry-standard triple-transient transfection for large scale AAV manufacturing:

  • Cost, scalability, batch to batch variability

  • Developing a stable, suspension-adapted inducible producer cell line (e.g. HEK293 or CHO-based host)

  • Vector design, clone selection, process optimisation

  • Improving full-to-empty capsid ratio and process scalability with innovative CLD approaches

16:30 - 17:00
Taming the Bioreactor: Process Development for Scaling Stable AAV Producer Lines

  • Optimising critical process parameters (CPPs) such as media composition, feed strategy, etc. for maximal vector yield

  • Characterising impact of bioreactor shear stress on cell health and viral particle quality

  • Process comparability and scalability from bench-scale to pilot-scale single-use bioreactors

16:00 - 16:30
The Clarification Bottleneck: Novel Filtration and Centrifugation Strategies for High-Density Cell Cultures
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
PANEL DISCUSSION: Collaboration - The Future Role Model for Resilient Biologics Supplies
  • Uwe Buecheler - Chairman of the Board, Biopharma Cluster South Germany
  • Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
16:00 - 16:30
The Clarification Bottleneck: Novel Filtration and Centrifugation Strategies for High-Density Cell Cultures
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
PANEL DISCUSSION: Collaboration - The Future Role Model for Resilient Biologics Supplies
  • Uwe Buecheler - Chairman of the Board, Biopharma Cluster South Germany
  • Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
16:00 - 16:30
An Automated Controlled Bioreactor Platform for Scalable 3D Expansion of induced Pluripotent Stem Cells
  • Andy Wiranata Wijaya - Bioprocess Development Lead, Nestlé Product Technology Center
16:30 - 17:00
PANEL DISCUSSION: The Platform Wars - The Future of Autologous, Allogeneic, and In Vivo Modalities
  • Terri Gaskell (Pending Final Confirmation) - CTO, Rinri Therapeutics
16:00 - 17:00
PANEL DISCUSSION: Closing the Digital Skills Gap

  • The ‘smart factory’ requires a smart workforce

  • Overcoming the digital skills gap in biomanufacturing:

    • Effective training strategies

    • Role of VR in operator training

    • Building a culture of continuous learning

    • Upskilling existing teams

  • Overall supporting digital transformation

  • Steven Fuller - Founder & Director, Race in STEM
  • Jason Beckwith, PhD DBA MBA - SVP Talent Science & Thought Leadership, BioTalent
  • Alessandro Cataldo, PhD - Process Development Scientist, Takeda
17:00 - 19:00
Offsite Networking Party
Main Conference Day 1 (28th April 2026)
NextMain Conference Day 3 (30th April 2026)
Filter
Streams
Choose Day